AKASA vs Solventum (formerly 3M Health Information Systems)
Two Autonomous Medical Coding vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| AKASA | Solventum (formerly 3M Health Information Systems) | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Subscription sized by transaction volume | Enterprise contract (custom) · Module-based licensing, quotes only |
| Speed to go live | 60-90 days typical; longer multi-facility | Enterprise install, deep EHR integration |
| Automation model | Autonomous agents · GenAI automation with human review | Software platform · CAC, CDI, grouping; autonomous coding add-on |
| Built for | Mid-size groups, Enterprise systems | Enterprise systems, Payers |
| Security posture | HITRUST, SOC 2 Type II, HIPAA | No certifications published |
| Company maturity | 8 yrs (est. 2018) | 2 yrs (est. 2024) |
| Financial backing | $205M · Series B | Public (NYSE: SOLV) |
| Named customers | 2 named | 1 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 3 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick AKASA if you run a mid-size or large health system, ideally on Epic, and want generative AI working claims, auths, and coding in-house instead of outsourcing staff.
- Pick Solventum if you are a large hospital that wants the incumbent market-standard coding, CDI, and grouping stack with decades of regulatory content behind it.
AKASA
Generative AI for coding and revenue cycle operations
- Founded
- 2018
- HQ
- South San Francisco, CA
- Stage
- Series B
- Raised
- $205M
What it does
- Generative AI medical coding trained on clinical documentation
- Clinical documentation integrity (CDI) review at scale
- Automates prior auth status and claims follow-up work
- LLMs fine-tuned on customer clinical and financial data
- Surfaces missed codes and documentation gaps pre-bill
Where it's strong
- Cleveland Clinic co-developed and is now deploying its GenAI CDI product across all US locations, a rare tier-one clinical validation.
- Deep pockets ($205M raised) and deployment across 650+ hospitals reduce vendor-viability risk.
- Focus on mid-revenue-cycle (coding plus CDI) fits health systems that want one vendor for both.
What buyers should weigh
- The company pivoted from RPA-style automation to generative AI, so ask which product generation you are actually buying.
- Flagship proof points are large academic systems; fit and pricing for smaller hospitals is less proven.
- Last disclosed raise was 2022, so probe current burn and roadmap funding.
Named customers
Cleveland Clinic · Duke University Health System
Integrations
Solventum (formerly 3M Health Information Systems)
The incumbent coding and CDI platform, adding autonomous coding
- Founded
- 2024
- HQ
- St. Paul, MN
- Stage
- Public (NYSE: SOLV)
- Raised
- n/a
What it does
- 360 Encompass computer-assisted coding and CDI platform
- Autonomous coding that finalizes 80%+ of qualified outpatient charts
- Over 1 million proprietary coding rules as guardrails
- Grouping, reimbursement, and quality methodologies (MS-DRG, APR-DRG)
- Semi-autonomous fallback workflow for complex visits
Where it's strong
- Decades of coding content, terminologies, and payment methodologies that startups have to rebuild from scratch.
- Already installed in most large US hospitals, so autonomous coding can be turned on without a new vendor relationship.
- Public-company stability and a compliance track record that eases legal and audit review.
What buyers should weigh
- Autonomous coding is a newer bolt-on to a legacy platform; automation rates and chart eligibility trail some startup claims, so test on your own case mix.
- Enterprise contracts are large and multi-year, with less pricing flexibility than per-chart startup models.
- The company is mid-restructuring after the 3M spinoff, with a $500M cost-cutting program that buyers should watch for support impact.
Named customers
Ensemble Health Partners
Integrations
Compare against the rest of Autonomous Medical Coding
Deciding between these two?
First Pass tracks Autonomous Medical Coding every week: funding, launches, and what changed since this page was written.